Sign in
4

Changes in Ownership

ENANTA PHARMACEUTICALS INC Filed Acc 0001177648-18-000032

President and CEO acquired 8,498 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Luly Jay R. · President and CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2018-07-27 Exercise or conversion : show line 1 in the form +8,498 $11.77 $99,990 601,524 D

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2018-07-27 Exercise or conversion : show line 2 in the form Stock Option (right to buy) −8,498 $11.77 2022-06-20 8,498 0 D
Loading xslF345X03/edgar.xml…